Clinical Trials Logo

Skin Aging clinical trials

View clinical trials related to Skin Aging.

Filter by:

NCT ID: NCT04532437 Completed - Skin Aging Clinical Trials

Computer-based Skin Aging Simulation for Skin Cancer Prevention

Start date: February 9, 2021
Phase:
Study type: Observational

This pilot study is to assess the knowledge, attitudes, and practices regarding skin cancer prevention in young adults and to determine the impact of artificial intelligence-based simulation of facial skin aging on their attitudes regarding skin cancer prevention.

NCT ID: NCT04276753 Completed - Skin Aging Clinical Trials

A Randomized, Double-blinded, Placebo Controlled, Monocentric Study to Evaluate the Anti-ageing and Skin Brightening Benefit of the Test Product in Healthy Female Subjects

Start date: September 3, 2020
Phase: N/A
Study type: Interventional

Every day the cells of the outer layer of skin die off, shed, and regenerate. When young, skin cells turn over quickly, but that turnover rate begins to slow with age, beginning as early as twenties. As a result, skin loses its luster and begins to look dull. Aging caused by the genes is inherited and is called intrinsic (internal) aging. The other type of aging is known as extrinsic (external) aging and is caused by environmental factors, such as exposure to the sun's rays. Skin ageing is mainly characterized by - 1. Decrease in thickness, firmness & elasticity of skin which results in wrinkles. 2. Reduction in antioxidant capacities. 3. Formation of spider veins and dark circles under the eyes. This study is proposed to evaluate skin antiaging efficacy along with the brightening attributes on face by visual assessment by Dermatologist, image analysis using VISIA CR, skin elasticity by Cutometer (MPA580) Hydration by Corneometer and skin texture by Antera 3 D and skin lightening/fairness by spectrophotometer, water barrier function by TEWL and to skin pH level by pH meter.

NCT ID: NCT04249128 Completed - Skin Aging Clinical Trials

Nourishing Hair, Skin & Nails Supplement Study (Derm Aid)

Start date: January 15, 2020
Phase: Phase 3
Study type: Interventional

A 90 day eight arm virtual interventional study looking at the impact of various supplement formulations for improves in hair, skin & nail health via self report, and dermatology assessment via remote dermatologist assessment.

NCT ID: NCT04141059 Completed - Skin Aging Clinical Trials

Effect of Oligopin® on Skin Ageing

OLIGOSKIN
Start date: November 19, 2019
Phase: N/A
Study type: Interventional

Extrinsic or exogenous ageing is caused by repetitive exposure of the skin to harmful agents, while primary cause the exposure to ultraviolet (UV) radiation, known as photoageing, including solar effect. Chronic solar UV exposure has multiple damaging effects on skin, such as wrinkling, dryness, dyspigmentation, epidermal thinning and increasing fragility. In addition, solar exposure and age increase a subepidermal band. Fibrillar collagen, which is synthesized from fibroblasts, is the predominant extracellular matrix (ECM) component of the dermis. Collagen type I and III are considered to be the major interstitial, fiber forming collagen in normal human dermis. In addition, the dermis contains collagen types IV (gelatine), V and VI. Other important component of the EMC of the dermis are elastic fibers being elastin (ELN) their main component and play a critical role in skin elasticity and the reduction of elastic fiber production results in impaired elasticity. UV radiation induces ECM degeneration and consequently an increase in fragility and loss of elasticity of the skin. This process is mediated by an increase in matrix metalloproteinases (MMPs) expression in human skin which are responsible for degrading ECM proteins, such as collagen, fibronectin and elastin. The natural inhibitors of MMPs are tissue inhibitors of metalloproteinases (TIMPs), being TIMP-1 the most relevant TIMP affecting collagen metabolism.

NCT ID: NCT04123743 Completed - Skin Aging Clinical Trials

Efficacy of Extract of Trigonella Foenum-graceum as Topical Phytoestrogen in Skin Aging Treatment of Post Menopausal Women

Start date: August 10, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Skin is subjected to intrinsic aging and extrinsic aging. Intrinsic aging is influenced by genetic and hormonal factors. Estrogen has significant role in modulating skin physiology. In post menopausal women, skin aging is accelerated because of hypoestrogenism. Administration of estrogen can delay the process of skin aging. Phytoestrogens are estrogen-like compounds which can be found naturally in plants. The investigators intend to study the efficacy of Trigonella foenum-graceum extract as topical phytoestrogen in skin aging treatment of post menopausal women.

NCT ID: NCT03677258 Completed - Skin Aging Clinical Trials

Effectiveness and Safety of Collagen Complex COLLOST in Anti-age Therapy

Start date: October 25, 2017
Phase: N/A
Study type: Interventional

This study evaluates the statistics of anti-age treatment in outpatient sites in Russia (involution indicators: clinical scales; instrumental diagnostics, ultrasonic scannings, assesment of allergic state, efficacy assesment in according with GAIS scale) in routine clinical practice with focus on collagen therapy.

NCT ID: NCT03529292 Completed - Skin Aging Clinical Trials

Pilot Study to Evaluate the Safety and the Efficacy of the Matrix and Cells Obtained by the AmeaCell® Device and Intended for the Filling of Wrinkles on the Face.

SKINMAT
Start date: July 9, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the filling using the Matrix and Cells, obtained by the Ameacell® device from autologous adipose tissue and intended for the filling of wrinkles on the face.

NCT ID: NCT03460860 Completed - Skin Aging Clinical Trials

Astaxanthin (2 mg) + Lycopene (1.8 mg) + D-Alpha-Tocopherol (10 IU) For The Treatment Of Skin Aging

Start date: March 5, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the clinical efficacy of a combination of Astaxanthin (2 mg), Lycopene (1.8 mg), and d-alpha-Tocopherol (10 IU) in terms of its skin anti-aging properties. Specifically, the investigators aim to determine the increase in hydration levels of the skin, decrease in atypical skin pigmentation, and reduction of signs of photoaging, particularly facial fine lines.

NCT ID: NCT03446079 Completed - Skin Aging Clinical Trials

Relationship of Skin Related SNP to Topical Skin Care Product

Start date: March 19, 2018
Phase: N/A
Study type: Interventional

Demonstrate the relationship between single nucleotide polymorphisms (SNP) and response to a topical skin care product.

NCT ID: NCT03424148 Completed - Skin Aging Clinical Trials

Open-label, Prospective, Multicenter Study to Evaluate the Cutera Excel V™ Laser and a Micro-Lens Array Attachment

Start date: February 20, 2018
Phase: N/A
Study type: Interventional

Open-label, Prospective, Study to Evaluate the Cutera excel V laser at 532 nm in a low fluence, high repetition rate mode and the Micro-Lens Array attachment used with excel V laser at 1064 nm and 532 nm for the improvement of skin quality.